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Abstract		DNA	end	resection	initiates	DNA	break	repair	by	homologous	recombination.	MRE11-RAD50-NBS1	and	phosphorylated	CtIP	perform	the	first	resection	step	by	MRE11-catalyzed	endonucleolytic	DNA	cleavage.	Human	NBS1,	more	than	its	Xrs2	homologue	from	Saccharomyces	cerevisiae,	is	crucial	for	this	process,	highlighting	complex	mecha-nisms	that	regulate	the	MRE11	nuclease	in	high	eukaryotes.	Using	a	reconstituted	sys-tem,	we	show	here	that	NBS1,	through	its	FHA	and	BRCT	domains,	functions	as	a	sensor	of	CtIP	phosphorylation.	NBS1	then	activates	the	MRE11-RAD50	nuclease	through	direct	physical	interactions	with	MRE11.	In	absence	of	NBS1,	MRE11-RAD50	exhibits	a	weaker	nuclease	activity,	which	requires	CtIP	but	not	strictly	its	phosphorylation.	This	identifies	at	least	two	mechanisms	by	which	CtIP	promotes	MRE11:	a	phosphorylation-dependent	mode	through	NBS1,	and	a	phosphorylation-independent	mode	without	NBS1.	In	sup-port,	we	show	that	limited	DNA	end	resection	in	absence	of	the	FHA	and	BRCT	domains	of	NBS1	occurs	in	vivo.	Collectively,	our	data	suggest	that	NBS1	restricts	the	MRE11-RAD50	nuclease	to	S-G2	phase	when	CtIP	is	extensively	phosphorylated.	This	defines	mechanisms	that	regulate	the	MRE11	nuclease	in	DNA	metabolism.	
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Introduction		The	maintenance	of	genomic	integrity	is	critically	important	as	cells	are	constantly	ex-posed	to	various	genotoxic	agents.	DNA	double-strand	breaks	(DSBs)	are	difficult	to	re-pair	due	to	the	loss	of	genetic	information	in	both	DNA	strands.	While	unrepaired	DSBs	may	result	in	cell	death,	their	inaccurate	repair	can	lead	to	mutagenesis	and	inappropri-ate	chromosomal	translocations	(Ranjha,	Howard	et	al.,	2018).	Cells	possess	two	main	mechanisms	for	DSB	repair.	This	includes	end-joining	pathways	including	Ku-dependent	non-homologous	end-joining	(NHEJ)	and	Ku-independent	microhomology-mediated	end-joining	(MMEJ),	which	are	functional	in	any	phase	of	the	cell	cycle	and	do	not	re-quire	a	DNA	template	(Ranjha	et	al.,	2018).	The	second	mechanism	is	template-dependent	homologous	recombination	(HR),	which	is	generally	restricted	to	the	S-G2	phase	of	the	cell	cycle.	The	sister	chromatid	serves	as	an	HR	template	in	most	cases	in	vegetative	cells,	explaining	why	recombination	can	only	function	in	the	cell	cycle	phases	when	sister	chromatids	are	available	(Ranjha	et	al.,	2018).	This	is	achieved	by	a	regula-tory	mechanism	involving	cyclin-dependent	kinases	(CDKs),	which	phosphorylate	key	factors	that	function	in	the	first	step	of	the	HR	pathway	termed	DNA	end	resection	(Huertas,	Cortes-Ledesma	et	al.,	2008,	Huertas	&	Jackson,	2009).	Resection	involves	nu-cleolytic	degradation	of	the	5'-terminated	DNA	strands	at	DSBs,	leading	to	3'	overhangs	that	are	essential	for	the	downstream	steps	in	the	recombination	pathway.	While	lim-ited	DNA	end	resection	may	be	involved	in	MMEJ,	DNA	that	underwent	extended	resec-tion	is	no	longer	ligatable	and	therefore	unsuitable	for	end-joining.	The	decision	wheth-er	and	to	which	extent	to	resect	DNA	ends	therefore	regulates	the	pathway	choice	in	DSB	repair	(Ranjha	et	al.,	2018).	The	MRE11-RAD50-NBS1	(MRN,	in	human	cells)	or	Mre11-Rad50-Xrs2	(MRX,	in	bud-ding	yeast)	complex	has	multiple	key	evolutionarily	conserved	functions	to	initiate	and	coordinate	the	repair	of	DSBs	(Paull,	2010,	Stracker	&	Petrini,	2011).	This	includes	roles	in	both	end-joining	and	HR	pathways	(Carney,	Maser	et	al.,	1998,	de	Jager,	van	Noort	et	al.,	2001,	Moore	&	Haber,	1996,	Paull	&	Gellert,	1998,	Paull	&	Gellert,	1999,	Rass,	Grabarz	et	al.,	2009).	Additionally,	MRN	promotes	DNA	end	tethering	and	is	required	to	signal	the	presence	of	DSBs	via	the	ATM	kinase	(Carney	et	al.,	1998,	de	Jager	et	al.,	2001,	Lee	&	Paull,	2005,	Stewart,	Maser	et	al.,	1999,	Usui,	Ogawa	et	al.,	2001,	Williams,	Moncalian	et	al.,	2008).	This	is	achieved	by	a	conserved	interaction	between	the	MRN	subunit	NBS1	(Xrs2	in	S.	cerevisiae)	and	ATM	(Tel1	in	yeast).	ATM	in	turn	phosphory-lates	hundreds	of	protein	targets	that	regulate	the	response	to	DSBs.	Beyond	ATM,	NBS1	also	interacts	with	MDC1,	which	binds	phosphorylated	proteins,	including	H2AX	
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(γH2AX),	to	amplify	the	DNA	damage	signaling	beyond	the	vicinity	of	the	DSB	(Goldberg,	Stucki	et	al.,	2003).	In	recombination,	the	MRN	complex	has	a	direct	role	in	DNA	end	re-section	mediated	by	the	MRE11	nuclease	in	the	S-G2	phase	of	the	cell	cycle.	MRE11	is	likely	the	first	nuclease	to	resect	DSBs,	which	is	particularly	important	for	the	pro-cessing	of	breaks	with	secondary	DNA	structures	or	protein	adducts	such	as	stalled	topoisomerases	or	Ku	(Anand,	Ranjha	et	al.,	2016,	Deshpande,	Lee	et	al.,	2016,	Reginato,	Cannavo	et	al.,	2018,	Shibata,	Moiani	et	al.,	2014,	Wang,	Daley	et	al.,	2017).	The	current	models	posit	that	resection	by	MRE11	is	initiated	by	endonucleolytic	DNA	cleavage	in-ternal	to	the	DSB	past	the	protein	block,	followed	by	3'→5'	exonucleolytic	degradation	back	toward	the	DNA	end	(Cannavo	&	Cejka,	2014,	Garcia,	Phelps	et	al.,	2011,	Keeney	&	Kleckner,	1995,	Neale,	Pan	et	al.,	2005,	Shibata	et	al.,	2014).	The	endonucleolytic	cleav-age	sites	also	represent	entry	sites	for	processive	DNA	end	resection	nucleases	that	function	downstream	of	MRN	in	the	5'→3'	direction,	including	EXO1	and	DNA2	(Gravel,	Chapman	et	al.,	2008,	Mimitou	&	Symington,	2008,	Nimonkar,	Genschel	et	al.,	2011,	Zhu,	Chung	et	al.,	2008).	The	MRN	nuclease	furthermore	likely	functions	to	promote	MMEJ	independently	of	the	cell	cycle,	which	to	date	remains	very	poorly	defined	(Deng,	Gibb	et	al.,	2014,	Ma,	Kim	et	al.,	2003,	Rahal,	Henricksen	et	al.,	2010,	Sharma,	Javadekar	et	al.,	2015,	Taylor,	Cecillon	et	al.,	2010,	Truong,	Li	et	al.,	2013).	The	processing	of	protein-blocked	DSBs	is	an	evolutionarily	conserved	capacity	of	MRE11	homologues	and	their	co-factors.	In	bacteria,	the	MRE11-RAD50-like	SbcC-SbcD	complex	endonucleotically	cleaves	DNA	near	blocked	DNA	ends	(Connelly,	de	Leau	et	al.,	2003).	Eukaryotic	cells	possess	a	third	member	of	the	MRE11-RAD50	complex,	NBS1/Xrs2,	as	well	as	CtIP/Sae2,	which	function	as	co-factors	of	the	MRE11	nuclease	in	resection	(Carney	et	al.,	1998,	Sartori,	Lukas	et	al.,	2007).	In	S.	cerevisiae,	Sae2	phos-phorylated	by	CDK	and	other	kinases	has	a	critical	function	to	promote	the	Mre11-Rad50	endonuclease	near	protein	blocks	(Cannavo	&	Cejka,	2014,	Huertas	et	al.,	2008,	Reginato	et	al.,	2018,	Wang	et	al.,	2017),	while	Xrs2	per	se	is	not	essential	for	the	DNA	clipping	reaction	in	vitro	(Oh,	Al-Zain	et	al.,	2016),	but	may	have	a	stimulatory	function	(Wang	et	al.,	2017).	It	has	been	demonstrated	that	Xrs2	is	responsible	for	the	nuclear	import	of	the	MRX	complex	(Carney	et	al.,	1998,	Tsukamoto,	Mitsuoka	et	al.,	2005).	When	this	function	was	bypassed	by	placing	the	nuclear	localization	signal	on	Mre11,	Xrs2	became	partially	dispensable	for	the	Mre11-Rad50-dependent	functions	in	resec-tion	also	in	vivo	(Oh	et	al.,	2016).	In	contrast,	Xrs2	per	se	was	strictly	required	for	the	DNA-damage	signaling	function	of	the	MRX	complex	(Oh	et	al.,	2016).		In	humans,	both	CtIP,	when	phosphorylated	by	CDK,	and	NBS1	promote	the	MRE11-RAD50	endonucle-ase	(Anand	et	al.,	2016,	Deshpande	et	al.,	2016).	The	comparatively	stronger	require-
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ment	for	NBS1	in	human	cells	with	respect	to	budding	yeast	likely	reflects	the	need	for	more	complex	regulatory	mechanisms	to	control	the	MRE11	nuclease	in	high	eukary-otes.	How	NBS1	performs	this	function	however	remains	poorly	characterized.	Beyond	DSB	processing,	unscheduled	DNA	degradation	by	MRE11	at	stalled	DNA	replication	forks	may	be	responsible	for	the	toxicity	associated	with	defects	in	BRCA1	or	BRCA2,	further	highlighting	the	importance	to	understand	how	MRE11	nuclease	is	regulated	in	human	cells	(Feng	&	Jasin,	2017,	Mijic,	Zellweger	et	al.,	2017,	Ray	Chaudhuri,	Callen	et	al.,	2016,	Schlacher,	Christ	et	al.,	2011).	Human	NBS1	consists	of	754	amino	acids.	The	N-terminus	contains	a	forkhead-associated	domain	(FHA)	and	tandem	BRCA1	C-terminal	(BRCT)	motifs	(BRCT1	and	BRCT2),	which	bind	phosphorylated	proteins,	including	CtIP	and	MDC1	(Spycher,	Miller	et	al.,	2008,	Wang,	Shi	et	al.,	2013,	Williams,	Dodson	et	al.,	2009).	At	its	C-terminal	part,	NBS1	contains	ATM	and	MRE11	interaction	sites,	as	well	as	three	potential	nuclear	lo-calization	signals	that	promote	the	nuclear	import	of	MRN	(Carney	et	al.,	1998,	Falck,	Coates	et	al.,	2005,	Nakada,	Matsumoto	et	al.,	2003,	Tsukamoto	et	al.,	2005,	You,	Chahwan	et	al.,	2005).	The	FHA	domain	of	S.	cerevisiae	Xrs2	binds	phosphorylated	Sae2,	although	this	capacity	appears	to	be	partially	dispensable	for	DNA	end	resection	in	vitro	and	in	vivo	(Liang,	Suhandynata	et	al.,	2015,	Oh	et	al.,	2016).	Structural	and	biochemical	characterization	of	MRN	in	Schizosaccharomyces	pombe	revealed	that	it	also	binds	phos-phorylated	Ctp1,	an	ortholog	of	CtIP/Sae2	in	S.	pombe,	through	the	FHA	motif	of	Nbs1	(Lloyd,	Chapman	et	al.,	2009,	Williams	et	al.,	2009).	A	point	mutation	that	affects	this	interaction	resulted	in	hypersensitivity	to	ionizing	radiation	and	camptothecin,	as	well	as	impaired	Ctp1	enrichment	at	DSBs	(Williams	et	al.,	2009).	Similarly	in	human	cells,	CtIP	phosphorylated	by	CDK	at	multiple	sites	in	the	center	of	the	protein	binds	the	FHA-BRCT	domains	of	NBS1,	which	is	important	for	DNA	end	resection	(Wang	et	al.,	2013).	However,	this	CDK-dependent	phosphorylation	was	also	important	for	the	subsequent	modification	of	T859	by	ATM	that	is	required	for	resection	in	vivo.	Phosphomimetic	T859E	could	partially	bypass	the	requirement	for	the	phosphorylation	of	CtIP	at	the	CDK	sites	at	the	center	of	the	protein	that	mediate	its	interaction	with	the	FHA-BRCT	domains	of	NBS1.	This	raised	questions	whether	modification	of	these	central	CDK	sites	is	required	for	resection	per	se,	or	only	serves	as	a	platform	to	help	phosphorylate	CtIP	at	T859	(Wang	et	al.,	2013).	Furthermore,	mutations	in	FHA-BRCT	abrogate	the	interac-tion	of	NBS1	with	MDC1,	which	may	have	an	indirect	effect	on	resection	as	a	result	of	disrupted	signaling	or	MRN	recruitment	(Hari,	Spycher	et	al.,	2010).	Because	of	the	mul-tiple	functions	of	the	MRN	complex	and	potential	pleiotropic	phenotypes	associated	
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with	NBS1	defects,	the	interpretation	of	cell-based	resection	assays	with	NBS1	variants	is	challenging.		Here,	we	primarily	employ	in	vitro	reconstituted	reactions	to	define	the	function	of	NBS1	in	DNA	end	resection	by	MRN-CtIP.	We	show	that	both	FHA	and	BRCT	domains	of	NBS1	promote	resection	by	MRE11	through	interactions	with	phosphorylated	CtIP.	When	NBS1	senses	that	CtIP	is	phosphorylated,	it	promotes	resection	by	a	mechanism	that	is	dependent	on	its	interaction	with	MRE11.	This	is	in	agreement	with	a	recent	study	showing	that	an	NBS1	fragment	containing	the	MRE11	binding	site	but	not	the	FHA-BRCT	domains	rescues	the	inviability	of		NBS1-deficient	mouse	embryonic	fibro-blasts	(Kim,	Grosbart	et	al.,	2017).	Importantly,	we	identify	an	NBS1-independent	DNA	cleavage	activity	of	MRE11-RAD50	and	CtIP.	Although	less	efficient	than	the	resection	capacity	of	the	MRN-CtIP	holocomplex,	the	NBS1-independent	activity	is	promoted	by	CtIP	but	surprisingly	does	not	strictly	require	its	phosphorylation.	Accordingly,	we	find	limited	CtIP-	and	MRE11-dependent	but	NBS1-independent	DSB	resection	activity	in	
vivo.	These	results	suggest	that	a	mechanism	that	interferes	with	the	function	of	NBS1	might	allow	limited	resection	in	the	absence	of	CDK-dependent	modification	of	CtIP,	which	might	be	relevant	for	understanding	MRE11	nuclease	functions	in	G1.					
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Results:		
NBS1	in	trans	promotes	endonucleolytic	cleavage	by	MRE11-RAD50	and	phos-
phorylated	CtIP	Previously,	we	showed	that	phosphorylated	CtIP	(pCtIP)	promotes	the	clipping	of	the	5'-terminated	DNA	strand	near	protein	blocked	DSBs	by	the	MRE11	nuclease	within	the	MRE11-RAD50-NBS1	(MRN)	complex	(Anand	et	al.,	2016).	This	reaction	is	believed	to	initiate	DNA	end	resection	by	MRN.	The	dsDNA	clipping	efficiency	of	MRE11-RAD50	(MR)	was	strongly	reduced	compared	to	MRN,	showing	that	NBS1	has	an	important	function	to	stimulate	this	activity	(Anand	et	al.,	2016,	Deshpande	et	al.,	2016).	To	define	the	function	of	NBS1	in	the	regulation	of	the	MRE11	nuclease,	we	purified	NBS1,	as	well	as	MR,	MRN	and	pCtIP	from	baculovirus-infected	Spodoptera	frugiperda	9	(Sf9)	insect	cells	(Fig	EV1A-D).		NBS1	was	purified	by	affinity	chromatography	by	utilizing	maltose	binding	protein	(MBP)	and	10x	histidine	(his)	tags,	located	at	the	N-	and	C-termini,	respectively.	As	the	removal	of	the	MBP	tag	by	PreScission	protease	cleavage	was	not	very	efficient	(Fig	EV1E),	the	MBP	tag	was	retained	during	the	final	purification	(Fig	EV1A).	MBP-NBS1-his	added	in	trans	promoted	dsDNA	clipping	by	MR	and	pCtIP	(Fig	1A	and	B).	This	was	al-most	as	efficient	as	DNA	cleavage	by	pCtIP	and	MRN	purified	as	a	complex,	where	NBS1	was	untagged	(Figs	1A,	B	and	EV1F).	Therefore,	the	affinity	tags	did	not	notably	impair	the	stimulatory	function	of	NBS1	on	dsDNA	clipping	by	MR	and	pCtIP	in	vitro.	To	further	confirm	this,	we	note	that	treatment	of	MBP-NBS1	with	PreScission	protease,	which	cleaves	~50%	of	the	MBP	tag	off	NBS1,	did	not	affect	dsDNA	clipping	efficiency	(Fig	EV1E	and	G).	The	MBP	tag,	expressed	separately,	did	not	affect	the	cleavage	capacity	of	MR	and	pCtIP	(Fig	EV1H-J).	Finally,	FLAG-NBS1-his	construct	promoted	DNA	cleavage	similarly	as	MBP-NBS1-his	(Fig	EV1K	and	L).	In	summary,	we	conclude	that	MBP-NBS1-his	(hereafter	NBS1	for	brevity)	added	in	trans	promotes	the	capacity	of	MR	and	pCtIP	ensemble	to	clip	5'-terminated	DNA	in	the	vicinity	of	protein	blocks.		
FHA	and	BRCT	domains	of	NBS1	are	important	for	the	processing	of	protein	
blocked	DSBs,	while	its	interaction	with	MRE11	is	essential	NBS1	mediates	physical	interactions	of	the	MRN	complex	with	ATM,	BRCA1,	BLM,	MDC1,	CtIP	and	possibly	other	factors	(Carney	et	al.,	1998,	Chen,	Nievera	et	al.,	2008,	Goldberg	et	al.,	2003,	Hari	et	al.,	2010,	Spycher	et	al.,	2008,	Stewart	et	al.,	1999,	Wang	et	
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al.,	2013,	Wang,	Cortez	et	al.,	2000,	Williams	et	al.,	2008).	Out	of	these,	the	interactions	with	CtIP	and	MDC1	are	at	least	in	part	phosphorylation-dependent.	To	specifically	de-fine	the	functional	interaction	of	NBS1	with	MR	and	pCtIP	in	resection,	we	employed	our	
in	vitro	reconstituted	system	(Anand	et	al.,	2016).	To	this	point,	we	prepared	NBS1	vari-ants	lacking	particular	domains	or	carrying	mutations	specifically	affecting	known	in-teractions	with	the	MR	and	pCtIP	ensemble	(Figs	2A	and	EV2A),	and	assayed	them	in	nuclease	assays	to	determine	their	effect	on	the	MRE11	endonuclease.		We	first	varied	the	concentrations	of	wild	type	NBS1	in	reactions	with	MR	and	pCtIP.	While	weak	NBS1-independent	DNA	cleavage	was	observed	(Fig	EV2B	and	C),	we	found	that	less	than	equimolar	concentrations	of	NBS1,	compared	to	the	MR	complex,	were	sufficient	for	maximal	DNA	clipping	activity	(Fig	EV2B	and	C).	We	next	tested	various	NBS1	fragments	lacking	FHA,	BRCT	or	both	domains	(Figs	2B	and	EV2D).	As	phosphory-lation	of	CtIP	is	required	for	resection	(Huertas	&	Jackson,	2009),	and	the	MRN	complex	primarily	binds	phosphorylated	CtIP	via	the	FHA	and	BRCT	domains	of	NBS1	(Fig	2C	and	D)(Wang	et	al.,	2013,	Williams	et	al.,	2009),	a	strong	defect	in	resection	was	antici-pated.	As	shown	in	Fig	2B,	a	deletion	of	either	FHA	or	BRCT	domain	in	NBS1	had	only	a	minor	effect	on	resection	in	vitro,	while	elimination	of	both	domains	significantly	re-duced,	but	did	not	eliminate	resection.	Similarly	to	the	elimination	of	both	FHA	and	BRCT	domains,	a	stronger	inhibitory	effect	was	observed	with	the	NBS1	RRHK	variant,	carrying	point	mutations	in	FHA-BRCT	(R28A,	R43A,	H45A	in	FHA	and	K160M	in	BRCT1,	Fig	2A	and	B)(Wang	et	al.,	2013).	The	RRHK	mutations	decreased	the	phosphor-ylation-dependent	interaction	of	NBS1	with	phosphorylated	MDC1	(Hari	et	al.,	2010),	as	well	as	with	pCtIP	(Fig	2C),	in	agreement	with	a	dramatic	DNA	end	resection	defect	in	
vivo,	as	scored	by	the	single-strand	annealing	reporter	assay	(Wang	et	al.,	2013).	Despite	the	strong	physical	interaction	between	the	FHA	and	BRCT	domains	of	NBS1	and	pCtIP	(Fig	2C),	which	is	dependent	on	CtIP	phosphorylation	(Fig	2D),	we	conclude	that	both	domains	of	NBS1	are	important,	but	not	essential	for	the	DNA	clipping	activity	in	vitro	together	with	MR	and	pCtIP.	Furthermore,	NBS1	(335-754),	which	lacks	FHA-BRCT	but	contains	a	central	linker	region,	exhibited	similar	stimulatory	activity	to	NBS1	(622-754)	lacking	the	central	region	(Fig	2B	and	E).	This	result	revealed	that	the	central	NBS1	region	(residues	335-621)	is	largely	dispensable	for	MR	and	pCtIP-mediated	resection,	despite	this	region	mediated	residual	interaction	with	pCtIP	(Fig	2C).	It	has	been	demonstrated	that	the	MRE11-RAD50	complex	directly	interacts	with	NBS1	
via	the	MRE11-interaction	region	(MIR)	within	the	C-terminal	part	of	NBS1,	with	the	most	important	motif	located	between	residues	684-690	of	NBS1	(Desai-Mehta,	
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Cerosaletti	et	al.,	2001,	Kim	et	al.,	2017,	Schiller,	Lammens	et	al.,	2012).	This	interaction	facilitates	MRN	entry	into	the	nucleus	as	only	NBS1	contains	the	nuclear	localization	se-quence.	Therefore,	in	vivo	experiments	with	mutated	MIR	of	NBS1	cannot	easily	distin-guish	effects	related	to	impaired	nuclear	entry	from	direct	effects	on	the	biochemical	activities	of	the	MR	complex.	Using	our	in	vitro	system,	where	any	effects	on	nuclear	im-port	are	irrelevant,	we	observed	that	in	contrast	to	the	FHA	and	BRCT	domains,	the	MRE11	interaction	region	in	NBS1	was	absolutely	essential	for	the	stimulatory	function	of	NBS1	on	the	MRE11-RAD50	endonuclease	in	conjunction	with	pCtIP	(Figs	2E	and	EV2E).	Specifically,	the	NBS1	(1-692)	fragment	lacking	the	very	C-terminal	region	of	NBS1,	but	possessing	MIR,	exhibited	similar	activity	as	full-length	NBS1	(Figs	2E	and	EV2D).	In	contrast,	the	NBS1	(1-683)	mutant	lacking	9	residues	comprising	MIR	(resi-dues	684-692)	completely	lost	its	stimulatory	activity	(Figs	2E	and	EV2E).	Likewise,	the	internal	deletion	of	MIR	(residues	684-690)	totally	abolished	NBS1	function	in	DNA	clipping,	even	at	high	concentrations	(Figs	2E	and	EV2E,	F).	In	accord	with	previous	studies	(Desai-Mehta	et	al.,	2001,	Schiller	et	al.,	2012),	we	observed	a	dramatic	reduc-tion	of	the	MRE11	and	NBS1	physical	interaction	when	NBS1	∆MIR	variant	was	used	in	pulldown	experiments	instead	of	wild	type	NBS1	(Fig	EV2G	and	H).	None	of	the	NBS1	variants	used	here	had	any	DNA	cleavage	activity,	as	expected	(Fig	EV2I).	In	summary,	the	NBS1-dependent	interaction	with	MRE11-RAD50,	more	than	that	with	pCtIP,	is	im-portant	for	the	endonuclease	activity	of	the	MRE11-RAD50	and	pCtIP	nuclease	ensem-ble.			
In	the	absence	of	pCtIP,	NBS1	promotes	MR	cleavage	independently	of	its	FHA	and	
BRCT	domains	Recently,	it	has	been	shown	that	NBS1	alone	is	capable	of	stimulating	the	endonucleolyt-ic	activity	of	MR	on	protein-blocked	dsDNA,	independently	of	CtIP	(or	pCtIP)(Deshpande	et	al.,	2016).	Although	CtIP-independent	DNA	end	resection	does	not	likely	occur	in	vivo	(Sartori	et	al.,	2007),	we	used	the	in	vitro	assay	to	learn	more	about	the	function	of	NBS1.	To	this	point,	we	employed	our	NBS1	mutants	in	an	MR-dependent	nuclease	as-say	with	streptavidin-blocked	dsDNA.	In	contrast	to	the	assays	that	included	pCtIP,	the	reactions	were	incubated	for	2	h	instead	of	30	min	to	compensate	for	the	lower	cleavage	efficacy	in	the	absence	of	pCtIP.	We	observed	that	all	NBS1	fragments	containing	MIR	stimulated	the	clipping	activity	of	MR	almost	indistinguishably,	irrespectively	of	FHA	and	BRCT	domains	(Fig	3A	and	B).	Notably,	one	of	these	constructs,	the	short	C-terminal	NBS1	fragment	containing	133	residues	(NBS1	622-754),	stimulated	the	endonucleolyt-
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ic	cleavage	to	the	same	extent	as	full-length	wild	type	NBS1.	Conversely,	NBS1	fragments	lacking	MIR	did	not	at	all	promote	MR	(Fig	3A	and	B).	Very	similar	results	were	obtained	using	circular	ssDNA	as	a	substrate,	which	forms	a	variety	of	secondary	DNA	structures	(Fig	EV3A	and	B).	However,	as	noted	previously,	we	believe	that	the	cleavage	of	dsDNA	near	protein	blocks	is	a	better	model	for	resection	taking	place	in	cells	(Fig	EV3C-G)	(Anand	et	al.,	2016,	Chen,	Trujillo	et	al.,	2005,	Deshpande,	Williams	et	al.,	2014).	In	summary,	we	show	that	in	the	absence	of	pCtIP,	the	phosphoprotein	binding	domains	of	NBS1	become	dispensable	for	resection	in	vitro.	Our	data	support	a	model	for	resection	in	wild	type	cells,	where	the	FHA-BRCT	domains	of	NBS1	promote	resection	by	first	binding	phosphorylated	CtIP,	and	NBS1	in	turn	activates	the	MR	complex	by	interacting	with	MRE11.		
BRCT	and	FHA	domains	of	NBS1	are	important	but	not	absolutely	essential	for	re-
section	in	vivo	To	verify	the	physiological	significance	of	our	data,	we	first	designed	an	NBS1	comple-mentation	system	in	U2OS	cells	to	define	the	requirement	of	the	FHA	and	BRCT	domains	of	NBS1	for	DNA	end	resection	in	vivo.	The	expression	of	endogenous	wild	type	NBS1	was	suppressed	with	siRNA,	and	siRNA	resistant	myc-tagged	NBS1	variants	were	ex-pressed	from	a	construct	containing	doxycycline-inducible	promoter	stably	integrated	into	chromosomal	DNA	(Fig	4A).	Downregulation	of	endogenous	NBS1	led	to	cellular	sensitivity	to	ionizing	radiation,	retention	of	MRE11	in	the	cytoplasm	and	a	DNA	end	resection	deficiency,	as	anticipated	(Figs	4B-E	and	EV4A-D).	Expression	of	wild	type	myc-tagged	NBS1	overcame	these	defects,	verifying	the	functionality	of	the	complemen-tation	system	(Figs	4B-E,	and	EV4A-D).	To	test	for	the	involvement	of	the	FHA	and	BRCT	domains	of	NBS1	in	resection,	we	gen-erated	cell	lines	expressing	wild	type	NBS1,	NBS1	R28A	(a	point	mutation	in	the	FHA	domain),	NBS1	K160M	(a	point	mutation	in	the	BRCT1	domain),	or	the	NBS1	R28A	K160M	double	mutant.	The	respective	point	mutations	in	the	FHA	and	BRCT	domains	affect	their	phosphorylation-dependent	protein	binding	function	(Cerosaletti	&	Concannon,	2003,	Hari	et	al.,	2010,	Wang	et	al.,	2013),	and	disrupted	the	interaction	with	CtIP	in	cell	extracts	(Fig	EV4E).	The	cell	lines	were	treated	with	siNBS1	for	72	h	to	knock	down	endogenous	NBS1	(Fig	4A).	For	the	last	24	h,	the	expression	of	the	comple-menting	NBS1	variant	was	induced	by	the	addition	of	doxycycline.	Cells	were	then	irra-diated	(5	Gy)	and	DNA	end	resection	was	scored	by	automated	counting	of	BrdU	foci	in	ssDNA	under	non-denaturing	conditions	or	by	counting	of	RPA2	foci	(Fig	4B-E).	Muta-
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tions	in	either	FHA	or	BRCT	domains	led	to	an	intermediate	defect	in	DNA	end	resection	in	both	resection	assays.	The	NBS1	R28A	K160M	double	mutant	led	to	a	more	severe,	but	not	complete	abrogation	of	resection,	comparable	to	NBS1	depletion	(Fig	4B-E).	Both	FHA	and	BRCT	domains	thus	individually	promote,	but	are	not	absolutely	essential,	for	the	DNA	end	resection	function	of	NBS1,	which	is	in	full	agreement	with	our	bio-chemical	analysis.	Depletion	of	CtIP	brought	about	a	more	severe	defect	than	that	of	NBS1,	and	nearly	completely	eliminated	BrdU	or	RPA2	foci	upon	IR	(Fig	4B-E).	This	result	confirmed	that	CtIP	is	essential	for	almost	all	DNA	end	resection	activity,	as	observed	previously	by	others	(Sartori	et	al.,	2007).	Furthermore,	the	depletion	of	NBS1	brought	about	lesser	defects	compared	to	CtIP	depletion	in	homologous	recombination	as	scored	by	a	DR-GFP	reporter	assay	(Fig	EV4F	and	G).	Finally,	depletion	of	NBS1	did	not	completely	elim-inate	single-strand	annealing	(SSA)(Fig	4F),	which	is	a	good	readout	for	extensive	DNA	end	resection	(Stark,	Pierce	et	al.,	2004).	We	also	note	that	the	residual	SSA	activity	ob-served	in	the	reporter	assay	without	NBS1	was	MRE11	dependent	(Fig	4F).		The	depletion	of	NBS1	by	siRNA	may	not	be	complete	and	may	thus	explain	the	residual	resection	we	observed.	To	this	point,	using	CRISPR/Cas9,	we	constructed	a	U2OS	hypo-morphic	NBS1ΔN	cell	line	that	expresses	low	levels	of	a	C-terminal	fragment	of	NBS1,	which	completely	lacks	the	FHA	and	BRCT	domains	(Fig	EV4H).	Similarly	as	in	mouse	embryonic	fibroblasts,	where	a	C-terminal	fragment	of	NBS1	rescued	viability	and	ATM	activation	(Kim	et	al.,	2017),	the	NBS1ΔN	cells	were	viable	and	grew	normally	in	the	ab-sence	of	exogenous	DNA	damage.	MRE11	was	partially	retained	in	the	cytoplasm	in	this	cell	line,	most	likely	owing	to	the	low	expression	level	of	the	hypomorphic	NBS1	allele	that	may	not	be	sufficient	to	fully	localize	MRE11	in	the	nucleus	(Fig	EV4I).	However,	stable	expression	of	recombinant	wild	type	or	NBS1	R28A	K160M	(C-terminally	tagged	with	the	monomeric	GFP	analogue	mNeonGreen),	fully	restored	MRE11	nuclear	localiza-tion	(Fig	EV4I).	DNA	end	resection	in	the	NBS1DN	cell	line	was	similarly	compromised	as	in	the	cells	depleted	from	NBS1	by	siRNA	(Fig	EV4J).	Consistent	with	our	siRNA-based	complementation	system,	stable	expression	of	wild	type	NBS1	in	the	NBS1DN	cell	line	efficiently	restored	DNA	end	resection	activity,	whereas	expression	of	the	NBS1	R28A	K160M	variant	did	not,	indicating	that	even	though	MRE11	nuclear	localization	was	re-stored	by	NBS1	R28A	K160M,	full	resection	activity	was	not	(Fig	4G).	Interestingly,	both	in	wild	type	and	NBS1	R28A	K160M	expressing	cells,	the	residual	resection	activity	was	dependent	on	CtIP	(Fig	4G),	thus	suggesting	that	CtIP	can	stimulate	resection	inde-pendently	of	NBS1	also	in	vivo.	Together,	we	demonstrated	that	limited	CtIP-dependent	
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DNA	end	resection	in	vivo	can	occur	without	the	involvement	of	FHA-BRCT	domains	of	NBS1.			
Phosphorylation	of	CtIP	is	partially	dispensable	for	stimulation	of	MR	in	the	ab-
sence	of	NBS1	NBS1	specifically	binds	phosphorylated	CtIP	(Fig	2D),	and	phosphorylation	of	CtIP	by	CDKs	is	key	for	stimulating	the	MRN	endonuclease	activity	(Anand	et	al.,	2016).	There-fore,	the	observation	that	limited	CtIP-dependent	resection	can	occur	without	the	FHA-BRCT	domains	of	NBS1	raised	the	question	whether	phosphorylation	of	CtIP	is	required	under	these	conditions.	In	Figs	2B	and	EV2B,	C,	we	observed	weak	NBS1-independent	resection	in	vitro.	To	better	define	the	mechanism	of	this	reaction,	we	modified	our	bio-chemical	assay	conditions	and	employed	the	extended	reaction	incubation	time	(2	h)	to	improve	the	detection	limit.	As	shown	in	Fig	5A	and	B,	we	observed	that	pCtIP	stimulat-ed	dsDNA	cleavage	by	MR	in	the	absence	of	NBS1	in	a	concentration-dependent	manner.	Our	previous	experiments	established	NBS1	as	a	reader	of	CtIP	phosphorylation,	and	the	NBS1-independent	reaction	thus	identifies	a	separate	mechanism	for	CtIP-facilitated	stimulation	of	MR.	Next,	we	set	out	to	test	whether	phosphorylation	of	CtIP	was	re-quired.	We	treated	or	mock-treated	pCtIP	with	λ	phosphatase.	As	shown	previously	(Anand	et	al.,	2016),	we	observed	that	only	pCtIP	(i.e.	mock-treated),	but	not	λCtIP,	stimulated	DNA	cleavage	by	MRN	in	a	concentration-dependent	manner	(Fig	5C-E).	In	contrast,	we	observed	a	robust	stimulation	of	MR-dependent	DNA	clipping	by	both	phosphorylated	and	λ	phosphatase-treated	CtIP	(Fig	5C-E).	Very	similar	results	were	obtained	in	kinetic	assays:	with	MRN,	pCtIP	was	~7-fold	more	efficient	in	promoting	the	DNA	cleavage	compared	to	λCtIP;	with	MR,	the	difference	was	only	~1.5-fold	(Figs	5F	and	G,	and	EV5A).	Therefore,	NBS1	appears	to	restrict	DNA	cleavage	by	MR	to	condi-tions	when	CtIP	is	phosphorylated.	Without	NBS1,	although	less	efficient,	the	MR-dependent	DNA	cleavage	is	more	promiscuous	and	can	occur	without	CtIP	phosphoryla-tion.	One	of	the	key	residues	in	CtIP	that	needs	to	be	phosphorylated	by	CDKs	to	allow	DNA	end	resection	during	S-phase	is	T847,	which	maps	to	a	conserved	region	that	is	equiva-lent	to	S267	of	S.	cerevisiae	Sae2	(Huertas	et	al.,	2008,	Huertas	&	Jackson,	2009).	Non-phosphorylatable	substitution	of	T847	with	alanine,	resulting	in	T847A	mutation,	ren-ders	pCtIP	incapable	to	promote	DNA	end	resection	(Anand	et	al.,	2016,	Huertas	&	Jackson,	2009).	Unexpectedly,	we	observed	that	the	pCtIP	T847A	mutant	was	incapable	to	promote	both	MR	and	MRN	(Fig	5H	and	I).	This	result	suggested	that	the	T847A	vari-
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ant	is	likely	structurally	impaired,	beyond	being	non-phosphorylatable	at	the	key	CDK	consensus	site.	Alternatively,	the	failure	of	pCtIP	T847A	to	promote	MR,	in	contrast	to	λCtIP,	may	stem	from	the	presence	of	other	phosphorylated	residues	in	pCtIP	T847A	that	have	an	inhibitory	function	together	with	MR.	To	test	for	this	scenario,	we	treated	pCtIP	T847A	with	λ-phosphatase,	and	observed	a	minor,	yet	statistically	significant,	res-cue	of	DNA	clipping	by	MR	(Fig	EV5B	and	C).	As	wild	type,	dephosphorylated	λCtIP	was	still	more	efficient	in	promoting	the	MR	endonuclease	than	dephosphorylated		λCtIP	T847A,	the	T847A	substitution	in	pCtIP	likely	brings	about	structural	changes	within	the	conserved	CtIP	region	that	affect	CtIP	activity	beyond	mimicking	a	non-phosphorylated	threonine.		Together,	our	results	demonstrate	that	NBS1,	as	CtIP,	is	a	co-factor	that	stimulates	the	DNA	cleavage	efficacy	of	the	MR	complex.	Reactions	with	MRN	require	CtIP	phosphory-lation,	and	lead	to	extensive	DNA	end	resection	activity	that	is	required	for	HR	and	SSA.	In	contrast,	in	the	absence	of	NBS1,	the	MR-dependent	cleavage	is	more	restricted,	and	CtIP	phosphorylation	is	partially	dispensable	for	the	DNA	cleavage	activity.			
The	physical	interaction	of	MRE11	and	RAD50	with	CtIP	does	not	require	CtIP	
phosphorylation	Our	observation	that	CtIP	was	able	to	stimulate	the	DNA	cleavage	capacity	of	the	MR	complex	prompted	us	to	define	physical	interactions	between	MRE11,	RAD50	and	phos-phorylated	or	non-phosphorylated	CtIP.	CtIP	is	known	to	interact	with	all	subunits	of	the	MRN	complex	(Chen	et	al.,	2008,	Sartori	et	al.,	2007,	Williams	et	al.,	2009,	Yuan	&	Chen,	2009);	in	accord,	we	detected	direct	interactions	between	pCtIP/CtIP	and	both	MRE11	and	RAD50	(Fig	6A	and	B).	While	phosphorylation	of	CtIP	was	absolutely	re-quired	for	its	interaction	with	NBS1	(Fig	2D),	it	was	not	the	case	for	MRE11	and	RAD50.	In	contrast,	λ	phosphatase-treated	CtIP	interacted	with	both	MRE11	and	RAD50	even	better	than	pCtIP,	suggesting	that	CtIP	phosphorylation	may	interfere	with	the	interac-tion	with	the	isolated	MRE11	and	RAD50	subunits	(Fig	6A	and	B).	We	cannot	exclude	that	the	apparent	increase	in	the	protein-protein	interactions	was	due	to	aggregation	of	non-phosphorylated	CtIP,	or	that	our	preparation	of	pCtIP	contained	phosphorylated	residues	that	are	not	normally	modified	in	vivo,	which	could	inhibit	the	interaction	with	MRE11	and	RAD50.	Nevertheless,	NBS1	was	mostly	responsible	for	the	interaction	be-tween	the	MRN	complex	and	pCtIP,	and	phosphorylation	of	CtIP	was	indispensable	for	this	interaction	(Fig	6C).	The	interaction	between	MRN	and	pCtIP	was	not	affected	by	the	presence	of	ATP	and/or	DNA	(Fig	EV6A).	Finally,	NBS1	largely	mediated	the	interac-
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tion	of	the	MRN	complex	even	when	DNA	bound	(Fig	EV6B).	In	summary,	the	interac-tions	of	MRE11	and	RAD50	with	CtIP	did	not	require	CtIP	phosphorylation.	These	data	are	in	agreement	with	the	results	from	the	nuclease	assays,	which	indicated	that	CtIP	phosphorylation	was	not	strictly	required	to	promote	the	nuclease	of	the	MR	complex.			
NBS1	is	dispensable	for	DNA	cleavage	opposite	to	a	strand	discontinuity	To	learn	more	about	the	involvement	of	NBS1	in	the	DNA	clipping	reaction,	we	em-ployed	a	substrate	that	contains	a	preexisting	nick	in	the	strand	opposite	to	the	antici-pated	cleavage	site,	which	was	shown	to	increase	the	efficacy	of	DNA	cleavage	(Deshpande	et	al.,	2016).	To	this	point,	we	performed	nuclease	analyses	with	both	nicked	and	non-nicked	DNA	substrates,	which	had	phosphorothioate	bonds	at	the	3'	ends	to	prevent	exonucleolytic	DNA	degradation	by	MRE11	(or	MR/MRN).	We	observed	that	MRE11	alone	had	no	endonuclease	activity	on	any	of	the	substrates	tested,	with	or	without	pCtIP,	as	expected	(Fig	7A	and	B,	lanes	3	and	6).	NBS1	promoted	the	cleavage	of	the	non-nicked	DNA	substrate	by	MR,	and	pCtIP	was	essential	(Fig	7A).	In	contrast,	NBS1	was	dispensable	when	nicked	DNA	substrate	was	used	(Fig	7B).	Under	these	con-ditions,	pCtIP	provided	a	moderate	stimulatory	effect,	with	or	without	NBS1	(Fig	7B).	The	same	results	were	obtained	in	kinetic	assays	(Fig	7C	and	D).	The	endonuclease	ac-tivity	was	promoted	by	a	nick	or	a	gap	in	the	top	strand,	as	a	substrate	lacking	the	top	left	oligonucleotide	was	not	endonucleolytically	cleaved	by	MR-pCtIP	or	MRN-pCtIP	(Fig	EV7).	Together,	our	results	suggested	that	NBS1,	and	to	a	lesser	extent	pCtIP,	is	dispen-sable	for	the	endonucleolytic	DNA	cleavage	in	case	of	a	pre-existing	nick	opposite	to	the	cleavage	site.			
Discussion	The	MRE11	nuclease	plays	critical	functions	at	DSBs	as	well	as	at	stalled,	collapsed	or	reversed	replication	forks	(Mijic	et	al.,	2017,	Schlacher	et	al.,	2011,	Stracker	&	Petrini,	2011).	Scheduled	activation	of	the	MRE11	nuclease	is	important	for	both	homologous	recombination	and	microhomology-mediated	end-joining	DSB	repair	pathways.	In	con-trast,	inappropriate	MRE11	nuclease	may	result	in	illegitimate	recombination	leading	to	genome	rearrangements	or	excessive	DNA	degradation	at	challenged	replication	forks,	leading	to	cell	lethality	in	certain	genetic	backgrounds	(Schlacher	et	al.,	2011).	There-fore,	the	activity	of	the	MRE11	nuclease	must	be	finely	controlled	and	restricted	to	situa-tions	when	it	is	appropriate	for	genome	stability	maintenance.	MRE11	is	a	3'→5'	exonu-
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clease	on	its	own	(Paull	&	Gellert,	1998).	In	complex	with	RAD50	and	other	co-factors,	MRE11	can	cleave	DNA	endonucleolytically	(Paull	&	Gellert,	1998,	Paull	&	Gellert,	1999).	It	is	believed	that	the	processing	of	DSBs	or	reversed	DNA	replication	forks	is	initiated	by	the	endonucleolytic	cleavage	of	the	5'-terminated	DNA	strand	by	MRE11	and	co-factors	(Cannavo	&	Cejka,	2014,	Garcia	et	al.,	2011,	Lemacon,	Jackson	et	al.,	2017,	Neale	et	al.,	2005).	Eukaryotic	cells	possess	two	key	regulators	of	the	MR	nuclease	complex:	CtIP/Sae2	and	NBS1/Xrs2.	In	yeast,	phosphorylated	Sae2	was	required	for	the	endonu-cleolytic	DNA	cleavage	by	MR,	while	the	lack	of	Xrs2	had	a	more	moderate	effect	(Oh	et	al.,	2016).	In	humans,	both	NBS1	and	phosphorylated	CtIP	promote	the	activity	of	the	MR	endonuclease,	revealing	that	NBS1	is	a	regulator	of	MRE11	that	appears	more	im-portant	in	high	eukaryotes	(Anand	et	al.,	2016,	Deshpande	et	al.,	2016).	In	this	study,	we	define	the	mechanism	by	which	NBS1	regulates	the	MRE11	endonuclease	using	primari-ly	a	reconstituted	in	vitro	system.		We	show	that	NBS1	functions	as	a	sensor	of	CtIP	phosphorylation,	which	allows	MRE11	nuclease	activation	only	when	CtIP	is	phosphorylated	(Fig	8A-C).	The	FHA	and	BRCT	are	highly	conserved	phosphoprotein	binding	domains,	which	mediate	the	physical	interac-tion	of	NBS1	with	phosphorylated	CtIP	and	both	these	domains	promote	resection	in	
vitro	as	well	as	in	vivo.	Once	NBS1	senses	that	CtIP	is	phosphorylated,	it	activates	the	MR	endonuclease,	which	is	dependent	on	a	direct	physical	interaction	between	NBS1	(resi-dues	684-692)	and	MRE11	(Fig	8A).	We	found	that	the	FHA	and	BRCT	domains	of	NBS1	are	important,	but	not	absolutely	essential	for	the	MR	and	pCtIP-dependent	cleavage	of	dsDNA	near	protein	blocks.	More	than	the	FHA-BRCT	domains,	the	short	region	within	the	C-terminus	of	NBS1	that	interacts	with	MRE11	is	absolutely	required	for	NBS1	to	promote	the	MR	complex	in	conjunction	with	pCtIP.	In	support	of	this	model,	we	ob-served	residual	NBS1-dependent,	but	pCtIP-independent	nuclease	activity	of	the	MR	complex	in	vitro	(Fig	8C).	Without	CtIP,	NBS1	still	promotes	DNA	cleavage	by	MR.	In	this	case,	the	FHA-BRCT	domains	of	NBS1	were	entirely	dispensable,	while	the	MRE11	inter-action	region	was	required.	Nevertheless,	while	this	in	vitro	reaction	informs	us	about	the	underlying	mechanism,	we	believe	that	CtIP-independent	resection	does	not	occur	
in	vivo,	as	depletion	of	CtIP	entirely	eliminated	resection	in	cells	in	all	assays	tested	(Fig	4)(Sartori	et	al.,	2007).	Next,	we	observed	that	in	the	absence	of	NBS1,	CtIP	still	promotes	the	endonuclease	of	MR,	albeit	to	a	lesser	extent.	This	functional	interaction	was	observed	in	vitro	(Fig	5),	as	well	as	in	cells	upon	NBS1	depletion	or	gene	editing	that	eliminated	the	FHA	and	BRCT	domains	of	NBS1	(Fig	4).	Strikingly,	CtIP	phosphorylation	was	not	strictly	required	in	
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the	absence	of	NBS1	(Figs	5C-G	and	8B).	While	these	data	are	in	agreement	with	the	function	of	NBS1	as	a	sensor	of	CtIP	phosphorylation,	the	result	was	nevertheless	sur-prising,	as	it	revealed	fundamental	differences	between	the	budding	yeast	and	human	systems.	In	yeast,	Sae2	phosphorylation	regulates	its	physical	interaction	with	Rad50	(Cannavo,	Johnson	et	al.,	2018),	in	addition	to	Xrs2	(Liang	et	al.,	2015).	Even	in	the	ab-sence	of	Xrs2,	Sae2	phosphorylation	is	still	fully	required	for	the	stimulation	of	the	Mre11-Rad50	endonuclease.	Using	human	proteins	instead,	we	found	that	the	phos-phorylation	of	CtIP	was	largely	but	not	completely	dispensable	for	the	activation	of	MR	in	the	absence	of	NBS1.	This	result	might	help	explain	how	CtIP	promotes	limited	resec-tion	in	G1.	It	is	well	established	that	CDK	and	ATM-dependent	phosphorylation	of	CtIP	is	necessary	for	the	activation	of	extended	resection	and	hence	homologous	recombination	in	S-G2	(Huertas	et	al.,	2008,	Huertas	&	Jackson,	2009,	Wang	et	al.,	2013).	Nevertheless,	CtIP	likely	activates	MRE11	in	MMEJ,	which	is	not	restricted	to	S-G2	and	requires	only	minimal	resection	(Averbeck,	Ringel	et	al.,	2014,	Dutta,	Eckelmann	et	al.,	2017,	Sharma	et	al.,	2015,	Truong	et	al.,	2013).	In	G1,	CtIP	is	phosphorylated	at	S327,	which	mediates	its	interaction	with	BRCA1,	but	the	G1	form	of	CtIP	will	likely	lack	other	phosphorylation	modifications	that	are	present	in	S-G2	(Biehs,	Steinlage	et	al.,	2017,	Yu	&	Chen,	2004).	We	speculate	that	this	form	of	CtIP	could	promote	the	MR	complex	in	case	the	NBS1	function	is	inhibited.	However,	we	were	unable	to	test	this	hypothesis	directly,	as	a	CtIP	variant	that	is	non-phosphorylatable	at	the	key	CDK	site	at	T847	appears	to	be	impaired	beyond	mimicking	a	non-phosphorylated	residue	(Fig	5H	and	I).	While	MRE11	and	RAD50	form	a	constitutively	interacting	dimer	of	dimers	complex,	there	are	conflicting	reports	about	the	stoichiometry	of	NBS1	within	the	MRN	complex	(Paull	&	Gellert,	1999,	Schiller	et	al.,	2012,	Trujillo,	Yuan	et	al.,	1998).	Furthermore,	it	has	been	reported	that	the	physical	interaction	of	NBS1	with	MR	may	be	differentially	regulated	in	G1	vs.	S-G2,	upon	DNA	damage	or	at	various	subcellular	locations,	such	as	at	telomeres	(Limbo,	Yamada	et	al.,	2018,	Zhou,	Kawamura	et	al.,	2017,	Zhu,	Kuster	et	al.,	2000).	Specifically,	the	MR	complex	was	shown	to	localize	to	DSBs	in	the	absence	of	NBS1	(Limbo	et	al.,	2018),	and	NBS1	co-localized	with	MR	to	telomeres	in	S	but	not	dur-ing	interphase	(Zhu	et	al.,	2000).	NBS1	also	shows	slower	kinetics	of	recruitment	to	DSBs	compared	to	MRE11	(Haince,	McDonald	et	al.,	2008).	Finally,	we	show	here	that	DNA	end	resection	was	strongly	reduced	but	not	completely	eliminated	in	the	absence	of	NBS1	in	cells,	despite	the	reduced	nuclear	import	of	MR,	showing	that	NBS1	may	not	be	an	obligate	component	of	the	resection	machinery	under	all	conditions.	Our	data	sug-gest	that	a	reduction	of	the	MR	interaction	with	NBS1	may	allow	the	complex	to	respond	to	non-phosphorylated	or	differently	phosphorylated	CtIP.	It	is	additionally	possible	
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that	the	function	of	NBS1	as	a	sensor	of	CtIP	phosphorylation	might	be	regulated	by	posttranslational	modifications	of	NBS1	(which	is	heavily	phosphorylated)	and/or	by	other	proteins	that	could	regulate	NBS1	function.	More	research	is	needed	to	fully	un-derstand	the	mechanisms	of	resection	in	G1,	and	the	involvement	of	MRN	and	CtIP	pro-teins	in	this	context.	Together,	our	results	demonstrate	that	the	MRE11-RAD50	endonu-clease	is	on	its	own	restricted	and	becomes	fully	functional	in	the	presence	of	NBS1	and	phosphorylated	CtIP.	By	regulating	these	co-factors	through	multiple	mechanisms,	cells	can	fine-tune	the	function	of	the	MR	endonuclease	to	optimally	promote	genome	stabil-ity	in	various	physiological	contexts.		
Material	and	Methods	
Cloning,	expression	and	purification	of	recombinant	proteins	
Recombinant	MRN,	MR	and	phosphorylated	CtIP	were	expressed	in	insect	Spodoptera	
frugiperda	9	(Sf9)	cells	and	purified	by	affinity	and	ion	exchange	chromatography	as	de-scribed	previously	(Anand,	Pinto	et	al.,	2018,	Anand	et	al.,	2016).	MBP-NBS1-his	and	its	variants,	as	well	as	MRE11-his	and	FLAG-NBS1-his	were	expressed	in	Sf9	cells	and	puri-fied	as	described	in	detail	in	Supplementary	information.	To	prepare	the	pFB-MBP-NBS1-his	expression	construct,	NBS1	was	amplified	from	pTP36	(a	kind	gift	from	Tanya	Paull,	University	of	Texas)	by	PCR	using	primers	NBS1_F	and	NBS1_R	(Tables	S1	and	S2).	The	PCR	product	was	digested	with	NheI	and	XmaI	(New	England	Biolabs)	and	cloned	into	corresponding	sites	of	pFB-MBP-MLH3-his	(Ranjha,	Anand	et	al.,	2014).	The	preparation	of	other	NBS1	variant	expression	constructs	is	described	in	Supplementary	information.	To	prepare	FLAG-NBS1-his,	a	NBS1	sequence	that	was	codon-optimized	for	expression	in	Sf9	cells	(NBS1co)	was	purchased	from	Synbio	Technologies	and	cloned	into	BamHI-XhoI	sites	of	pFB-MBP-NBS1-his	to	create	pFB-FLAG-NBS1co-his.	To	pre-pare	pFB-MBP-MRE11-his,	the	MRE11	gene	was	amplified	by	PCR	from	pTP17	(a	kind	gift	from	Tanya	Paull,	University	of	Texas)	using	primers	HMRE11-FO	and	HMRE11-RE	(Tables	S1	and	S2).	The	amplified	product	was	digested	with	NheI	and	XmaI,	and	cloned	into	the	same	sites	in	pFB-MBP-Sgs1-his	plasmid	(Cejka	&	Kowalczykowski,	2010);	the	sequence	of	Sgs1	was	removed	during	this	step.		The	scheme	and	sequences	of	oligonu-cleotides	used	for	cloning	of	the	NBS1	fragments	and	all	other	constructs	in	this	study	are	listed	in	Tables	S1	and	S2.	Where	indicated,	1.2	μg	pCtIP	was	dephosphorylated	in	20	μl	reactions	with	200	units	of	λ	phosphatase	(λ-PP,	New	England	Biolabs)	in	1x	PMP	buffer	(New	England	Biolabs)	supplemented	with	1	mM	magnesium	chloride	for	15	min	
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at	30°C.	For	"mock"	control,	λ-PP	was	excluded	from	the	reaction.	
Nuclease	assays	Unless	indicated	otherwise,	nuclease	assays	(15	μl	volume)	were	carried	out	in	nuclease	buffer	containing	25	mM	Tris-HCl	pH	7.5,	5	mM	magnesium	acetate,	1	mM	manganese	acetate,	1	mM	dithiothreitol	(DTT),	1	mM	ATP,	0.25	mg/ml	BSA	(New	England	Biolabs),	1	mM	phosphoenolpyruvate	(Sigma),	80	U/ml	pyruvate	kinase	(Sigma),	and	1	nM	oligo-nucleotide-based	DNA	substrate	(in	molecules).	Unless	specified	otherwise,	the	final	NaCl	concentration	in	the	reactions	was	adjusted	to	15	mM,	accounting	for	salt	brought	to	the	reactions	with	protein	storage	or	dilution	buffer.	The	reactions	were	supplement-ed	with	15	nM	streptavidin	(Sigma),	and	incubated	for	5	min	at	room	temperature	to	block	the	biotinylated	end(s)	of	the	DNA	substrates.	The	recombinant	proteins	were	then	added	to	the	reactions	on	ice	and	samples	were	incubated	at	37°C	for	30	min,	un-less	indicated	otherwise.	Reactions	were	stopped	by	adding	0.5	μl	of	0.5	M	ethylenedia-minetetraacetic	(EDTA)	and	1	μl	Proteinase	K	(19	mg/ml,	Roche),	and	incubated	at	50°C	for	30	min.	Finally,	15	μl	loading	buffer	(5%	formamide,	20	mM	EDTA,	bromophenol	blue)	was	added	to	all	samples	and	the	products	were	separated	on	15%	polyacryla-mide	denaturing	urea	gels	(19:1	acrylamide-bisacrylamide,	Bio-Rad),	as	described	(Pinto,	Anand	et	al.,	2018).	The	gels	were	fixed	in	fixing	solution	(40%	methanol,	10%	acetic	acid,	5%	glycerol)	for	30	min	at	room	temperature	and	dried	on	a	3MM	Chr	paper	(Whatman).	The	dried	gels	were	exposed	to	storage	phosphor	screen	(GE	Healthcare)	and	scanned	by	a	Typhoon	Phosphor	Imager	(FLA	9500,	GE	Healthcare).	Nuclease	as-says	with	circular	ssDNA	substrate	(M13,	100	ng	per	reaction,	New	England	Biolabs)	were	carried	out	similarly	except	the	reaction	buffer	contained	60	mM	NaCl	and	incuba-tion	time	was	extended	to	2	h.	The	reaction	products	were	separated	on	1.1%	agarose	gels,	which	were	stained	with	GelRed	(1:20000,	Biotium)	after	completion	of	electro-phoresis	for	45	min.	The	gels	were	imaged	with	gel	imager	(Ingenius3,	Syngene).	
Preparation	of	oligonucleotide-based	DNA	substrates		All	oligonucleotides	were	purified	by	polyacrylamide	gel	electrophoresis	and	purchased	from	Eurogentec.	The	labeling	of	oligonucleotides	at	the	5'-end	was	carried	out	by	T4	polynucleotide	kinase	(New	England	Biolabs)	and	[γ-32P]	ATP	(Perkin	Elmer).	The	label-ing	of	oligonucleotides	at	the	3'-end	was	carried	out	by	terminal	deoxynucleotidyl	trans-ferase	(New	England	Biolabs)	and	[α-32P]	cordycepin	5'	triphosphate	(Perkin	Elmer),	as	described	(Pinto	et	al.,	2018).	To	prepare	quadruple	blocked	70-bp	long	DNA	substrate,	PC210	and	PC211	oligonucleotides	were	used,	as	described	previously	(Cannavo	&	
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Cejka,	2014).	To	prepare	single-blocked	non-nicked	substrate	(Fig	7A),	PC216C_5XSS	(GATGCATGAGGTGGAGTACGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGCACCGCGGCA*C*T*T*A*C)	was	labeled	at	5'-end	and	annealed	with	PC216_5XSS	(GTAAGTGCCGCGGTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCACCTCAT*G*C*A*T*C),	the	bold	T	represents	the	biotin	modification	and	*	represent	phos-phorothioate	linkages	between	nucleotides.	To	prepare	the	single	blocked	nicked	sub-strate	(Fig	7B),	PC216C_5XSS	labeled	at	5'-end	was	annealed	with	PC216_50nt	(GTAAGTGCCGCGGTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCG)	and	PC216_20nt_5XSS	(CGTACTCCACCTCAT*G*C*A*T*C).	To	prepare	substrate	used	in	Fig	EV7,	PC216C_5XSS	labeled	at	5'-end	was	annealed	to	PC216_20nt_5XSS.	
Protein	interaction	assays	
To	test	for	interactions	between	recombinant	proteins,	the	"bait"	proteins	were	first	immobilized	on	a	resin	(either	M2	anti	FLAG	affinity	gel	[Sigma]	or	Protein	G	agarose	[Invitrogen]	coupled	to	specific	antibodies).	The	resin	was	then	incubated	with	"prey"	proteins	in	binding	buffer,	washed,	and	bound	proteins	were	analyzed	by	western	blot-ting.	As	a	negative	control,	prey	proteins	were	incubated	with	resin	without	bait	pro-teins.	
Specifically,	to	detect	the	interaction	between	pCtIP	and	NBS1	variants	(Fig	2C	and	D),	1.5	μg	anti	CtIP	antibody	(Active	Motif,	61141)	was	captured	on	10	μl	protein	G	beads	upon	incubation	in	150	μl	PBS-T	pH	7.4	(1.37	mM	NaCl,	2.7	mM	KCl,	10	mM	Na2HPO4,	1.8	mM	KH2PO4,	0.1%	Tween	20)	for	40	min	at	room	temperature	with	continuous	rota-tion.	Next,	1	μg	recombinant	CtIP	(mock-treated	pCtIP	or	dephosphorylated	λCtIP)	was	added	and	incubated	in	60	μl	binding	buffer	(25	mM	Tris-HCl	pH	7.5,	1	mM	DTT,	3	mM	EDTA,	50	mM	NaCl,	0.2	mg/ml	BSA)	for	1	h	at	4°C	with	continuous	rotation.	The	resin	with	the	immobilized	antibody	was	washed	2	times	with	150	μl	wash	buffer	(25	mM	Tris-HCl	pH	7.5,	1	mM	DTT,	3	mM	EDTA,	80	mM	NaCl,	0.05%	Triton-X),	and	incubated	with	320	nM	NBS1	variants	in	60	μl	binding	buffer	for	1	h	at	4°	C	with	continuous	rota-tion.	The	resin	was	then	washed	3	times	with	150	μl	wash	buffer.	The	proteins	were	eluted	by	incubation	of	the	washed	resin	for	3	min	at	95°C	in	60	μl	SDS	buffer	(50	mM	Tris-HCl	pH	6.8,	1.6%	sodium	dodecyl	sulphate,	100	mM	DTT,	10%	Glycerol,	0.01%	bromophenol	blue).	CtIP	and	NBS1	variants	were	detected	by	western	blot	using	anti	CtIP	(Active	Motif,	61141,	1:1000)	and	anti	NBS1	(Novus	Biologicals,	NB100-143,	1:1000)	antibodies.	In	assays	shown	in	Figs	6C	and	EV6A,	90	nM	MRE11,	MR	or	MRN	was	incubated	with	immobilized	λCtIP	or	pCtIP	as	described	above.	MRE11	was	detect-
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ed	with	anti-MRE11	antibody	(Abcam,	ab214,	1:1000).		
To	detect	the	interaction	between	MRE11-his	and	MBP-NBS1-his/MBP-NBS1	∆MIR-his,	or	between	MRE11-his	and	pCtIP/λCtIP	as	shown	in	Figs	EV2H	and	6A,	respectively,	1.4	μg	MRE11-his	was	immobilized	on	beads	and	coupled	to	anti	MRE11	antibody	(Abcam,	ab214).	After	washing,	200	nM	MBP-NBS1-his/MBP-NBS1∆MIR-his,	or	330	nM	pCtIP/λCtIP	were	incubated	with	the	MRE11-coated	resin	in	a	60	μl	reaction	in	binding	buffer	as	described	above.	For	the	assay	shown	in	Fig	EV2H,	both	MRE11-his	and	MBP-NBS1-his/MBP-NBS1	∆MIR-his	were	detected	by	anti	his	antibody	(MBL,	M091-3,	1:1000)	by	western	blotting.		
For	the	interaction	assay	shown	in	Fig	6B,	50	ml	Sf9	cells	were	infected	with	RAD50-FLAG	baculovirus.	Cells	were	lysed	and	RAD50-FLAG	(~300	ng)	was	immobilized	on	30	μl	anti	FLAG	M2	affinity	gel.	Next,	in	a	150	μl	reaction,	330	nM	pCtIP/λCtIP	was	added	and	incubated	in	binding	buffer	for	1	h	at	4°C	with	continuous	rotation.	Beads	were	washed	4	times	with	300	μl	wash	buffer	and	proteins	were	eluted	with	wash	buffer	sup-plemented	with	3X	FLAG	peptide	(150	ng/μl,	Sigma).	Bound	RAD50-FLAG	was	detected	by	western	blotting	using	anti	FLAG	antibodies	(Sigma,	F3165,	1:2000).		
For	FLAG	co-IP	experiments	(Fig	EV4E),	293-T	cells	were	co-transfected	with	FLAG-CtIP	expression	constructs	(Sartori	et	al.,	2007)	and	NBS1-myc	expression	constructs	(Hari	et	al.,	2010).	Immunoprecipitations	were	done	using	Anti	FLAG	M2	affinity	beads	(Sig-ma,	A2220).	Western	blots	were	probed	with	rabbit	anti	FLAG	(Sigma,	F7425)	and	mouse	anti	myc	(GeneTex,	9E10,	GTX80249)	antibodies.	
DR-GFP	and	SSA	reporter	assays	
For	DR-GFP	HR	repair	reporter	assays,	DR-GFP	U2OS	cells	(a	gift	from	J.	Stark)	were	plated	at	20’000	cells/cm2	in	6-well	plates.	After	24	h,	cells	were	transfected	with	con-trol	siRNA	or	siRNA	against	CtIP	(5’-GCUAAACAGGAACGAAUCTTdTdT-3’)	 and	NBS1	(5’-GGAGGAAGAUGUCAAUGUUTTdTdT-3’),	respectively.	48	h	after	siRNA	transfection,	cells	were	transfected	with	I-SceI	expression	plasmid	(pCBASce).	4	h	after	transfection,	the	medium	was	replaced	and	a	second	transfection	with	siRNA	oligonu-cleotides	was	carried	out.	48	h	after	I-SceI	transfection,	cells	were	analyzed	for	GFP	ex-pression	by	flow	cytometry	on	a	LSRII	Fortessa	flow	cytometer	(BD).	For	the	SSA	re-porter	assays,	0.4	x105	SA-GFP	U2OS	cells	were	seeded	in	0.5	ml	antibiotic	free	media	onto	24	well	plates	with	5	pmol	siRNA	(siCTRL,	5'-TGGTTTACATGTCGACTAA;	siCtIP,	5'-GCTAAAACAGGAACGAATC;	siNBS1,	5'-GGAGGAAGATGTCAATGTT)	and	1.8	μl	RNAiMAX	
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(Invitrogen)	in	100	μl	Opti-MEM	(Gibco)	and	cultured	overnight	(20	h).	Following	RNAi	treatment,	the	cells	were	transfected	with	0.4	μg	I-SceI	(pCBASce)	and	0.2	μg	empty	vec-tor	(pcDNA3.1)	with	Lipofectamine	2000	(Invitrogen)	in	100	μl	Opti-MEM	and	0.5	ml	antibiotic	free	media	for	3	h.	After	the	I-SceI	transfection,	cells	were	washed	and	treated	with	MRE11	inhibitors	50	μM	PFM03	and	50	μM	PFM39	(a	kind	gift	from	Davide	Moiani	and	John	Tainer	(MD	Anderson	Cancer	Center)	(Shibata,	Moiani	et	al.,	2014)	or	mock	treated	with	DMSO	and	cultured	for	3	days.	GFP	positive	cells	were	quantified	on	an	LSRFortessa	flow	cytometer	(BD). 
Generation	of	siRNA-based	NBS1	complementation	system	in	U2OS	cells	
To	generate	the	siRNA-based	complementation	system	for	NBS1,	the	Flp-InTM	T-RExTM	system	(Thermo	Fisher	Scientific)	was	used	according	to	the	manufacturer’s	protocols.	Briefly,	myc-tagged	full-length	NBS1	cDNAs	(wild	type	and	mutants)	were	sub-cloned	from	retroviral	expression	constructs	(Hari	et	al.,	2010)	and	ligated	into	the	pcDNA5/FRT/TO	vector.	Silent	mutations	were	introduced	in	the	siRNA	target	sequence	(see	below)	by	site-directed	mutagenesis	using	the	following	mutagenesis	primer	(sense):	5’-GTTCAAAAACAGGAGGAAGACGTGAACGTTAGAAAAAGGCCAAGG-3’.	A	Flp-In	T-REx	U2OS	cell	line	(gift	from	D.	Durocher)	was	cultured	in	Dulbecco’s	modified	Eagle	medium	(DMEM),	supplemented	with	10%	fetal	calf	serum	(FCS),	2	mM	L-glutamine	and	penicillin-streptomycin	antibiotics	under	standard	cell	culture	conditions	in	a	CO2	incu-bator	(37°C;	5%	CO2).	NBS1-myc	harboring	vectors	and	the	Flp-In	recombinase	expres-sion	plasmid	pOG44	were	mixed	in	a	1:9	ratio	and	transfected	into	the	Flp-In	T-REx	U2OS	cells.	Stable	clones	were	established	by	Hygromycin	B	(250	µg/ml)	and	Blasticidin	(10	µg/ml)	selection	and	were	characterized	for	inducible	NBS1-myc	expression	by	im-munofluorescence	and	western	blotting.		
Generation	of	the	NBS1DN	cell	line	
The	NBS1DN	cell	line	was	generated	according	to	a	protocol	published	by	the	Zhang	la-boratory	(Ran,	Hsu	et	al.,	2013).	The	sgRNA	target	sequence	(5’-GCGTTGAGTACGTTGTTGGA-3’)	was	cloned	into	the	PX330-U6-hSpCas9	vector	and	veri-fied	by	sequencing.	The	targeting	vector	was	then	transfected	into	U2OS	cells	and	clonal	cell	lines	were	isolated	by	dilution	in	96-well	plates.	Single	clones	were	analyzed	for	NBS1	expression	by	immunofluorescence.	Several	clones	without	detectable	NBS1	ex-pression	were	isolated	and	one	of	them	was	further	characterized	(data	will	be	pub-lished	elsewhere).	Frame-shift	inducing	insertion/deletion	(indel)	mutations	in	all	of	the	three	NBS1	alleles	present	in	U2OS	cells	were	verified	by	Sanger	sequencing	of	a	PCR-
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amplified	genomic	fragment	that	was	cloned	in	the	pCR	II	Blunt	TOPO	plasmid	(se-quences	will	be	published	elsewhere),	indicating	that	the	FHA	BRCT	domain	coding	re-gion	was	eliminated.	Western	blotting	however	revealed	the	presence	of	weakly	ex-pressed	~40	kDa	protein	that	is	recognized	by	a	monoclonal	antibody	raised	against	full-length	NBS1	(Genetex,	clone	1D7,	GTX70224),	which	was	sensitive	to	downregula-tion	of	the	NBS1	mRNA	by	siRNA	transfection,	thus	suggesting	that	this	cell	line	ex-presses	low	levels	of	hypomorphic	C-terminal	fragment	of	NBS1	that	is	produced	by	in-ternal	translation	initiation	within	the	NBS1	mRNA	using	an	open	reading	frame	gener-ated	by	one	of	the	indel	mutations,	similar	to	the	NBS1	hypomorphic	alleles	expressed	in	cell	lines	derived	from	NBS	patients	(Maser,	Zinkel	et	al.,	2001).		
In	vivo	resection	assay	
U2OS	cell	lines	were	grown	on	coverslips	for	24	h	prior	to	treatment.	When	indicated,	cells	were	transfected	with	siRNAs	against	NBS1	or	CtIP	(siRNA	sequence	indicated	in	the	previous	section	where	the	generation	of	siRNA-based	NBS1	complementation	sys-tem	was	explained)	and	incubated	for	72	h.	For	heterologous	expression	of	full-length	recombinant	myc-tagged	NBS1,	doxycyclin	(1	µg/ml)	was	added	24	h	prior	to	the	exper-iment.	For	BrdU	staining	under	native	conditions,	BrdU	(10	µg/ml)	was	also	added	24	h	prior	to	the	experiment.	Cells	were	exposed	to	5	Gy	of	IR	and	then	incubated	for	3	h	at	37°C.	The	medium	was	removed,	and	cells	were	washed	with	PBS,	followed	by	a	brief	pre-extraction	on	ice	in	CSK	buffer	(100	mM	PIPES,	pH	7.0;	100	mM	NaCl;	300	mM	Su-crose;	3	mM	MgCl2;	0.4%	Triton	X-100).	Cells	were	then	fixed	in	4%	paraformaldehyde,	washed	and	prepared	for	immunofluorescence	analysis	(see	below).		
Immunofluorescence		
Cells	were	grown	on	glass	coverslips	and	fixed	with	either	ice-cold	methanol	for	10	min	(for	staining	with	NBS1	and	MRE11	antibodies),	or	with	4%	buffered	formaldehyde	(for	staining	with	all	other	antibodies)	for	15	min	at	room	temperature,	and	subsequently	permeabilized	for	5	min	in	PBS	containing	0.2%	Triton	X-100.	Following	1	h	of	blocking	in	blocking	buffer	(10%	FBS,	3%	BSA	in	PBS),	primary	antibody	incubations	were	per-formed	at	room	temperature	for	2	h.	Coverslips	were	washed	three	times	with	PBS	and	secondary	antibody	incubations	were	performed	for	1	h	at	room	temperature	in	the	dark.	After	washing	with	PBS	for	three	times,	coverslips	were	mounted	on	glass	micros-copy	slides	with	Vectrashield	mounting	medium	containing	0.5	μg/ml	4’,6-diamidino-2-phenylindole	dihydrochloride	(DAPI).	Widefield	image	acquisition	was	done	on	either	a	
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Leica	DMI6000B	inverted	microscope	equipped	with	a	63x	Apochromat	oil	immersion	objective	(NA	1.3)	using	Leica’s	LAS-AF	software	or	on	a	Zeiss	AxioObserver	Z1	wide-field	microscope,	equipped	with	a	Lumencor	SpectraX	illumination	system	and	a	63x,	1.4-NA,	i-plan	apochromat	oil-immersion	objective,	using	Zeiss’	ZEN	(blue	edition)	soft-ware.	Images	were	analyzed	using	Fiji	software	(Schindelin,	Arganda-Carreras	et	al.,	2012).	Counting	of	BrdU	foci	or	RPA2	foci	was	done	with	a	Fiji	macro	written	for	auto-matic	image	analysis.	The	following	antibodies	were	used	at	the	indicated	dilutions:	rabbit	anti	NBS1	(Novus	Biologicals,	NB100-143,	1:500),	affinity	purified	sheep	anti	MRE11	(Goldberg	et	al.,	2003,	1:1000),	mouse	anti	Myc	(GeneTex,	9E10,	GTX80249,	1:250),	mouse	anti	BrdU	(Amersham/GE	healthcare,	BU-1,	RPN202,	1:100),	mouse	anti	RPA2	(Abcam,	9H8,	ab2175,	1:250).	
Western	blotting	of	total	cell	extracts	
SDS-PAGE	and	western	blotting	were	performed	using	total	extracts	prepared	from	cul-tured	cells	following	standard	procedures.	The	following	antibodies	were	used	at	the	indicated	dilutions:	rabbit	anti	ATMpS1981	(Eptimics,	YE070901r,	1:5000),	rabbit	anti	ATM	(Calbiochem,	PC-116,	1:250),	mouse	anti	CtIP	(Santa	Cruz,	sc-271339,	1:250),	mouse	anti	NBS1	(GeneTex,	1D7,	GTX70224,	1:500),	mouse	anti	RPA2	(Abcam,	9H8,	ab2175,	1:500),	rabbit	anti	SMC1	(Abcam,	ab9262,	1:500),	mouse	anti	RAD50	(GeneTex,	13B3,	GTX70228,	1:1000),	mouse	anti	MRE11	(Abcam,	12D7,	ab214,	1:500),	mouse	anti	Myc	(GeneTex,	9E10,	GTX80249,	1:250),	mouse	anti	Tubulin	(Sigma,	DM1A,	T6199,	1:2000).	For	western	blot	shown	in	Fig	4F,	the	following	antibodies	were	used:	rabbit	anti	NBS1	(Novus	Biologicals,	NB100	143,	1:1000),	mouse	anti	CtIP	(Active	Motif,	61141,	1:1000),	mouse	anti	β	actin	(Abcam,	ab8227,	1:1000)		
Clonogenic	survival	assay	
U2OS	FlpIn	T-REx	cell	lines	were	transfected	with	siNBS1	for	48	h	and	then	plated	at	low	density	in	medium	supplemented	with	0.5	µg/ml	doxycycline.	24	h	later,	the	plates	were	exposed	to	the	indicated	IR	doses,	followed	by	incubation	for	12-14	days.	Colonies	were	fixed	and	stained	with	Coomassie	brilliant	blue	and	the	number	of	surviving	colo-nies	for	each	cell	was	counted.	The	percentage	of	surviving	colonies	for	each	cell	line	was	calculated	using	the	plating	efficiencies	of	the	non-irradiated	cells	as	a	reference.	Survival	experiments	were	carried	out	in	biological	triplicates.	
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Figure	Legends	
	
Figure	1	-	NBS1	in	trans	with	MR	and	pCtIP	cleaves	DNA	similarly	as	MRN-pCtIP.	A A	representative	nuclease	assay	with	MR,	MBP-NBS1-his	(denoted	MBP-NBS1),	MRN	and	pCtIP	on	5’-end	labeled	70-bp	dsDNA	with	all	ends	blocked	with	streptavidin.	Samples	were	separated	on	15	%	denaturing	polyacrylamide	gel.		B Quantitation	of	nuclease	assays	such	as	in	(A).	Averages	shown;	n	=	3;	error	bars,	SEM.			
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Figure	2	-	FHA	and	BRCT	domains	of	NBS1	are	important	for	MR-pCtIP	stimulation	
while	MRE11-NBS1	interaction	is	essential.		A A	schematic	representation	of	purified	recombinant	wild	type	NBS1	and	variants.	All	constructs	were	MBP	tagged	at	the	N-	and	his-tagged	at	the	C-terminus.	B The	effect	of	mutations	in	FHA	and/or	BRCT	domains	of	NBS1	on	the	nuclease	of	MR	and	pCtIP.	Quantitation	of	experiments	such	as	shown	in	Fig	EV2D.	Averages	shown;	n	≥	4,	error	bars,	SEM.	Statistical	significance	denotations	represent	the	analysis	be-tween	wild	type	full-length	NBS1	(in	black)	and	the	corresponding	concentrations	of	the	NBS1	variants;	ns	(p	>	0.05,	not	significant),	*	(p	<	0.05),	**	(p	<	0.01),	***	(p	<	0.001),	two-tailed	t-test.	C Analysis	of	pCtIP	binding	to	NBS1	variants.	Anti	CtIP	antibody	was	immobilized	on	Protein	G	agarose,	bound	to	pCtIP,	and	tested	for	interactions	with	the	indicated	NBS1	variants	(see	cartoon	at	the	top).	Western	blot	of	eluates	(right	part)	was	performed	with	anti-CtIP	and	anti-NBS1	antibodies.	Left	part	(input)	indicates	that	the	anti-NBS1	antibody	recognizes	the	NBS1	constructs	to	a	similar	level.		D Analysis	of	phosphorylated	CtIP	(pCtIP,	mock-treated)	or	λ	phosphatase	treated	CtIP	(λCtIP)	interactions	with	NBS1.	The	CtIP	variants	were	immobilized	on	protein	G	agarose,	and	incubated	with	NBS1	(see	cartoon	on	the	left).	The	western	blot	was	per-formed	with	anti	CtIP	and	anti	NBS1	antibodies.		E The	effect	of	the	MRE11	interaction	region	(MIR)	of	NBS1	on	the	nuclease	of	MR	and	pCtIP.	Quantitation	of	experiments	such	as	shown	in	Fig	EV2E	.	Averages	shown,	n	≥	3,	error	bars,	SEM.	The	quantitation	of	wild	type	NBS1	(NBS1	WT,	in	black)	is	the	same	as	in	panel	(B)	and	is	shown	again	for	reference.		
Figure	3	-	Without	pCtIP,	NBS1	promotes	the	MR	endonuclease	independently	of	
its	FHA	and	BRCT	domains.	A Nuclease	assays	with	MR	and	various	NBS1	fragments	(50	nM)	on	oligonucleo-tide-based	5'-end	labeled	dsDNA.	The	reaction	buffer	contained	60	mM	NaCl	and	reac-tions	were	incubated	for	2	h.	B Quantitation	of	experiments	such	as	shown	in	(A).	Averages	shown;	n	≥	3,	error	bars,	SEM.			
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Figure	4	-	The	function	of	NBS1	in	DNA	end	resection	in	vivo.	A A	schematic	representation	of	the	NBS1	knockdown-rescue	experiments	in	U2OS	cells.	B In	vivo	resection	assay	using	BrdU	staining	under	native	conditions	to	directly	de-tect	ssDNA	at	sites	of	DSBs.	Shown	are	representative	images.	C In	vivo	resection	assay	using	RPA2	staining	as	a	marker	for	ssDNA	present	at	sites	of	DSBs.	Shown	are	representative	images.	D Quantitation	of	the	experiment	shown	in	B.	At	least	100	cells	were	assessed	per	condition.	E Quantitation	of	the	experiment	shown	in	C.	At	least	100	cells	were	assessed	per	condition.	F Quantitation	of	the	single	strand	annealing	(SSA)	reporter	assay	in	U2OS	cells.	All	cells	were	treated	with	DMSO;	where	indicated,	both	PFM03	(50	μM)	and	PFM39	(50	μM)	MRE11	inhibitors	were	added.	Averages	shown;	n	=	4,	error	bars,	SEM.	Insert,	western	blot	analysis	of	NBS1	and	CtIP	protein	levels	upon	depletion	with	siRNA.	G Quantitation	of	resection	activity	in	NBS1DN	cells	complemented	with	wild	type	(WT)	or	NBS1	R28A	K160M	mutant	and	either	mock	depleted	(siCtrl)	or	depleted	of	CtIP	(siCtIP).	At	least	300	cells	were	assessed	per	condition.	Statistical	significance	was	determined	using	ordinary	one-way	ANOVA	with	Tukey’s	multiple	comparison	test.		
Figure	5	-	Phosphorylation	of	CtIP	is	partially	dispensable	for	MR	stimulation	in	
the	absence	of	NBS1.	A Nuclease	assays	with	MR	and	pCtIP	on	3’-end	labeled	dsDNA,	incubated	for	2	h.		B Quantitation	of	experiments	such	as	shown	in	(A).	Averages	shown;	n	=	2;	error	bars,	range.		C Nuclease	assays	with	MRN,	MR	and	various	concentrations	of	pCtIP	(mock-treated)	or	λCtIP	on	5’-end	labeled	dsDNA,	incubated	for	2	h.		D Quantitation	of	experiments	such	as	shown	in	(C).	Averages	shown;	n	=	3;	error	bars,	SEM.		
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E Phosphorylated	CtIP	was	mock-incubated	(pCtIP,	lane	2)	or	treated	with	λ	phos-phatase	(λCtIP,	lane	3).	The	proteins	were	separated	on	a	10%	polyacrylamide	gel	and	stained	with	Coomassie	brilliant	blue.	F Quantitation	of	kinetic	nuclease	assays	with	MRN	and	pCtIP	(mock-treated)	or	λCtIP.	Averages	shown;	n	=	3;	error	bars;	SEM.	Statistical	denotations,	**	(p	<	0.01),	two-tailed	t-test.	G Quantitation	of	nuclease	assays	as	in	(F),	but	with	MR	complex	instead	of	MRN.	Averages	shown;	n	=	3;	error	bars,	SEM.	Statistical	denotations,	ns	(p	>	0.05),	two-tailed	
t-test.	H Nuclease	assays	with	MR,	MRN,	pCtIP	or	pCtIP	T847A,	as	indicated,	on	5'-end	la-beled	dsDNA.	Reactions	were	incubated	for	2	h.	I Quantitation	of	experiments	such	as	shown	in	(H).	Averages	shown;	n	=	4;	error	bars,	SEM.			
Figure	6	-	CtIP	phosphorylation	is	dispensable	for	its	interaction	with	MRE11	and	
RAD50.		A Interaction	between	MRE11	and	CtIP.	MRE11	was	immobilized	on	antibody-coupled	Protein	G	agarose,	and	incubated	with	pCtIP	or	λCtIP	(see	cartoon).	Western	blot	analysis	of	bound	proteins	was	performed	with	anti	MRE11	and	anti	CtIP	antibod-ies.		B Interaction	between	RAD50	and	CtIP.	RAD50-FLAG	was	immobilized	on	anti-FLAG	affinity	resin	and	incubated	with	pCtIP	and	λCtIP	(see	cartoon).	Western	blot	analysis	of	bound	proteins	was	performed	with	anti	FLAG	and	anti	CtIP	antibodies.		C Interaction	between	MRE11,	MR	or	MRN	and	pCtIP	or	λCtIP,	as	indicated.	Phos-phorylated	(pCtIP)	or	λ	phosphatase-treated	CtIP	(λCtIP)	were	immobilized	on	anti-body-coupled	Protein	G	agarose,	and	incubated	with	MRE11,	MR	or	MRN	complexes	(see	cartoon).	Bound	proteins	were	analyzed	by	western	blot	using	anti	CtIP	and	anti	MRE11	antibodies.			
Figure	7	-	NBS1	is	not	required	for	DNA	cleavage	opposite	to	a	nick.		
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A Representative	nuclease	assays	with	MRE11,	MR,	MRN	and	pCtIP,	as	indicated,	on	5'-end	labeled	dsDNA	with	a	single	streptavidin-blocked	end	(S).	The	substrate	con-tained	5	phosphorothioate	bonds	(PTO)	at	both	3'-ends	to	prevent	exonucleolytic	DNA	degradation.	Reactions	were	incubated	for	2	h.		B Representative	nuclease	assays	as	in	(A),	but	with	a	substrate	containing	a	nick	in	the	top	oligonucleotide	(20	nt	away	from	the	3'-end,	see	cartoon).		C Quantitation	of	experiments	such	as	shown	in	(A),	with	pCtIP.	Averages	shown;	n	≥	4;	error	bars,	SEM.	D Quantitation	of	experiments	such	as	shown	in	(B),	with	and	without	pCtIP.	Aver-ages	shown;	n	=	3;	error	bars,	SEM.		
Figure	8	-	A	model	for	MRN	and	CtIP	functions	in	endonucleolytic	DNA	cleavage.	A When	phosphorylated	CtIP	and	MRN	are	present	(in	S-G2),	CtIP	phosphorylation	is	detected	by	the	FHA	and	BRCT	domains	of	NBS1	(1),	which	in	turn	promotes	DNA	cleavage	by	MR	via	direct	interaction	with	MRE11,	mediated	by	the	MRE11-interaction	region	of	NBS1	(2).	This	results	in	maximal	DNA	end	resection	activity	compatible	with	homologous	recombination.	B In	the	absence	of	NBS1	function	(see	text),	CtIP	promotes	the	nuclease	of	MR	in	a	reaction	that	is	partly	independent	of	its	phosphorylation	(3).		This	results	in	low	resec-tion	activity	of	MR,	which	may	be	sufficient	for	limited	resection	in	G1.	C In	the	absence	of	CtIP,	NBS1,	through	its	MRE11-interaction	region,	but	inde-pendently	of	its	FHA	and	BRCT	domains,	promotes	the	MR	endonuclease	(4).	This	activi-ty	is	likely	very	limited	and	therefore	unlikely	to	be	physiologically	relevant.			
Expanded	View	Figure	Legends	
	
Expanded	View	Figure	1	(related	to	figure	1)	A A	representative	10%	polyacrylamide	gel	showing	purification	of	recombinant	MBP-NBS1-his.	The	gel	was	stained	with	Coomassie	brilliant	blue.	Amylose	flowthrough	and	eluate,	flowthrough	and	eluate	from	amylose	resin;	Ni-NTA	flowthrough	and	eluate,	flowthrough	and	eluate	from	nickel-nitrilotriacetic	acid	(Ni-NTA).	*	indicates	truncated	products.		
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B Samples	from	a	representative	purification	of	the	MR	complex	were	analyzed	by	10%	polyacrylamide	gel	electrophoresis.	The	gel	was	stained	with	Coomassie	brilliant	blue.	FLAG	flowthrough	and	eluate,	flowthrough	and	eluate	from	anti-FLAG	affinity	res-in.	C Samples	from	a	representative	purification	of	the	MRN	complex	analyzed	by	10%	polyacrylamide	gel	electrophoresis.		D Samples	from	a	representative	purification	of	phosphorylated	CtIP	(expressed	and	purified	with	phosphatase	inhibitors)	analyzed	by	10%	polyacrylamide	gel	electropho-resis.	MBP,	maltose	binding	protein;	PP,	PreScission	protease.	E Polyacrylamide	gel	stained	with	Coomassie	brilliant	blue	showing	the	partial	cleavage	of	MBP-NBS1-his	by	PreScission	protease	(PP).	The	PP	recognition	site	is	in	between	the	MBP	tag	and	NBS1.	2	μg	recombinant	MBP-NBS1-his	was	incubated	for	1	h	at	4°C	with	1	μg	of	PreScission	protease.	F Nuclease	assays	as	in	Fig	1A	but	with	3’-end	labeled	70-bp	dsDNA.	G Nuclease	assays	with	MR	and	pCtIP	and	either	uncleaved	(left	panel)	and	partially	cleaved	MBP-NBS1	(right	panel,	~50%	cleaved)	with	PreScission	protease.	5’-end	la-beled	70	bp-long	dsDNA	was	used	as	a	substrate.			H Polyacrylamide	gel	stained	with	Coomassie	brilliant	showing	purified	recombi-nant	MBP	tag.	I Nuclease	assays	with	MR,	pCtIP,	MBP-NBS1	or	MBP,	as	indicated.	5’-end	labeled	70	bp-long	dsDNA	was	used	as	a	substrate.		MBP	tag	does	not	affect	the	nuclease	reac-tions.	J Quantitation	of	assays	such	as	in	(I).	Averages	shown;	n	=	3;	error	bars,	SEM.	K Polyacrylamide	gel	stained	with	Coomassie	brilliant	showing	purified	recombi-nant	MBP-NBS1-his	and	FLAG-NBS1-his.	*	indicates	truncated	product.		L Nuclease	assays	with	MR	and	pCtIP	and	either	MBP-NBS1-his	(left	panel)	or	FLAG-NBS1	(right	panel).		3’-end	labeled	70	bp-long	dsDNA	was	used	a	substrate.			
	
Expanded	View	Figure	2	(related	to	figure	2)	
	 35	
A A	representative	polyacrylamide	gel	(4-15%)	stained	with	Coomassie	brilliant	blue	showing	purified	NBS1	variants.	All	constructs	were	MBP	tagged	at	the	N-	and	his-tagged	at	the	C-terminus.	B A	representative	nuclease	assay	with	MR,	pCtIP	and	various	concentrations	of	MBP-NBS1-his	(labeled	NBS1)	on	3’-end	labeled	dsDNA.	C Quantitation	of	experiments	such	as	shown	in	(B).	Averages	shown;	n	=	5;	error	bars,	SEM.		D Representative	nuclease	assays	with	MR,	pCtIP	and	various	MBP-NBS1-his	frag-ments	(10	nM)	containing	MRE11-interaction	region	(MIR),	using	3'-end	labeled	dsDNA	as	a	substrate.		E Representative	nuclease	assays	with	MR,	pCtIP	and	various	NBS1	fragments	(10	nM)	lacking	MRE11-interaction	region	(MIR)	on	3’-end	labeled	dsDNA.		F Representative	nuclease	assays	with	MR,	pCtIP	and	various	concentrations	of	MBP-NBS1∆MIR,	using	3'-end	labeled	dsDNA	as	a	substrate.	G A	representative	10%	polyacrylamide	gel	stained	with	Coomassie	brilliant	blue	showing	purified	recombinant	MRE11-his.		H Interaction	of	MRE11	with	NBS1.	MRE11	was	immobilized	on	antibody-coupled	Protein	G	agarose,	and	incubated	with	MBP-NBS1-his	or	MBP-NBS1∆MIR-his	(see	car-toon).	Bound	proteins	were	analyzed	by	western	blot	with	anti-his	antibodies.		I Nuclease	assay	with	NBS1	variants,	showing	that	these	proteins	alone	do	not	pos-sess	any	nuclease	activity.		
Expanded	View	Figure	3	(related	to	figure	3)	A Nuclease	assays	with	MR	and	various	NBS1	fragments	(50	nM)	on	M13	ssDNA.	The	reaction	products	were	separated	on	agarose	gels	(1.1%).	The	reaction	buffer	con-tained	60	mM	NaCl	and	reactions	were	incubated	for	2	h.	B Quantitation	of	experiments	such	as	shown	in	(A).	Averages	shown;	n	=	3,	error	bars,	SEM.	C Nuclease	assay	with	MR	and	MBP-NBS1-his	(denoted	NBS1),	with	and	without	ATP	on	5'-end	labeled	dsDNA.	The	reaction	buffer	contained	60	mM	NaCl	and	reactions	
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were	incubated	for	2	h.	The	DNA	cleavage	reaction	requires	ATP,	in	agreement	with	ob-servations	that	ATPase-deficient	RAD50	mutants	are	incapable	of	resection	in	vivo.		D Quantitation	of	experiments	such	as	shown	in	(C).	Averages	shown,	n	=	2,	error	bars,	range.	E Nuclease	assays	with	MR	and	MBP-NBS1-his	(denoted	NBS1),	with	and	without	ATP,	using	M13	ssDNA	as	a	substrate.	The	reaction	buffer	contained	60	mM	NaCl	and	reactions	were	incubated	for	2	h.	The	reactions	were	separated	on	1.1%	agarose	gel.	ATP	did	not	stimulate	M13	ssDNA	cleavage.	F Quantitation	of	experiments	such	as	shown	in	(E).	Averages	shown;	n	=	2,	error	bars,	range.	G Nuclease	assay	with	MR	and	MBP-NBS1	as	in	panel	(E),	but	with	or	without	RPA.	RPA	inhibits	M13	ssDNA	cleavage	(this	panel)	and	ATP	is	partially	dispensable	(see	panels	E	and	F).	In	cells,	RPA	is	ubiquitous	and	RAD50	ATPase-deficient	mutants	are	in-capable	of	resection.	Therefore,	we	believe	that	the	M13-based	assays	do	not	accurately	mimic	the	reaction	occurring	in	vivo,	and	that	the	clipping	of	dsDNA	(see	Fig	3A	and	B)	is	a	better	model.		
Expanded	View	Figure	4	(related	to	figure	4)	A Western	blot	of	FlpIn	T-REx	NBS1-myc	expressing	cells.	Expression	of	recombi-nant	NBS1	was	induced	for	24	h	with	doxycycline	(DOX)	prior	to	extract	preparation.	B Clonogenic	survival	assay	showing	that	expression	of	siRNA-resistant	recombi-nant	NBS1	rescues	radiosensitivity	of	NBS1-depleted	cells.	C Immunofluorescence	experiment	showing	efficient	depletion	of	NBS1	by	siRNA	and	cytoplasmic	localization	of	MRE11	in	the	NBS1-depleted	cells.	Expression	of	myc-tagged	NBS1	restored	MRE11	nuclear	localization.	D Western	blot	showing	efficient	depletion	of	NBS1	and	CtIP	by	siRNA	transfection	and	expression	of	siRNA-resistant	myc-tagged	recombinant	wt	NBS1	and	variants.		E NBS1	R28A	and	K160M	mutations	impair	the	interaction	between	NBS1	and	CtIP	in	cell	extracts.	Flag-CtIP	and	NBS1-myc	variants	were	overexpressed	in	293-T	cells,	where	indicated.	Anti-FLAG	affinity	resin	was	used	to	pulldown	FLAG-CtIP	and	in-teracting	partners.	
	 37	
F Western	blot	showing	the	downregulation	of	CtIP	and	NBS1	upon	siRNA	treat-ment	in	the	HR	reporter	assays	in	G.	G HR	repair	reporter	assay	after	CtIP	and	NBS1	depletion.	Bars	and	error	bars	rep-resent	mean	and	SD	of	4	independent	experiments.	Statistical	significance	was	tested	by	unpaired	t-test	(p=0.02).	H Western	blot	of	extracts	prepared	from	wild	type	U2OS	cells,	NBS1DN	cells	and	NBS1DN	cells	stably	expressing	mNeonGreen	(mNG)	tagged	wild	type	(WT)	and	R28A	K160M	NBS1	mutant	full-length	NBS1,	either	mock-depleted	(siCtrl)	or	depleted	of	CtIP	(siCtIP)	by	siRNA.	Note	the	presence	of	a	presumably	hypomorphic	40	kDa	C-terminal	fragment	of	NBS1	(NBS1hm)	in	the	NBS1DN	cell	line.	I Immunofluorescence	of	NBS1DN	U2OS	cells	stably	expressing	mNeonGreen	(mNG)	tagged	wild	type	(WT)	and	R28A	K160M	mutant	full-length	NBS1.	Note	that	MRE11	nuclear	localization	is	partially	impaired	in	NBS1DN	cells,	which	is	fully	rescued	by	heterologous	expression	of	NBS1	wt	and	R28A	K160M	mutant.	J Quantitation	of	resection	activity	as	scored	by	RPA	foci	in	wild	type	U2OS	cells	and	NBS1DN	cells.	At	least	260	cells	were	assessed	per	condition.			
Expanded	View	Figure	5	(related	to	figure	5)	A Representative	nuclease	assays	with	MR,	MRN	and	pCtIP	or	λCtIP	using	5'-end	la-beled	dsDNA.	Quantitation	of	these	and	similar	experiments	is	shown	in	Fig	5F	and	G.	Reactions	were	incubated	for	2	h.	B Nuclease	assays	with	MR	and	pCtIP	T847A	or	λCtIP	T847A	on	5'-end	labeled	dsD-NA.	Reactions	were	incubated	for	2	h.	C Quantitation	of	experiments	such	as	shown	in	(B).	Averages	shown;	n	=	4;	error	bars,	SEM.	Statistical	denotations,	**	(p	<	0.01),	two-tailed	t-test.		
Expanded	View	Figure	6	(related	to	figure	6)	A Interaction	assays	as	in	Fig.	6C,	but	with	ATP	(2	mM	ATP,	10	mM	magnesium	ace-tate,	no	EDTA)	or	ATP/DNA	(2	mM	ATP,	10	mM	magnesium	acetate,	no	EDTA,	20	nM	dsDNA	resulting	from	annealing	PC210	and	PC211	oligonucleotides,	in	molecules).	The	No	ATP/DNA	reactions	contained	10	mM	magnesium	acetate	and	lacked	EDTA.		
	 38	
B Electrophoretic	mobility	shift	assays	with	MR,	MRN	and	either	pCtIP	or	λCtIP.	The	substrate	was	5'	labeled	dsDNA	that	was	not	blocked	with	streptavidin.	The	reaction	buffer	was	the	same	as	in	nuclease	assays,	except	pyruvate	kinase	and	phosphoenol	py-ruvate	were	omitted.	The	binding	reactions	were	carried	out	on	ice	for	15	min,	and	sep-arated	by	0.6%	agarose	at	4	°C.		
Expanded	View	Figure	7	(related	to	figure	7)	Nuclease	assays	as	in	Fig	7B,	but	with	a	substrate	missing	the	top	left	oligonucleotide.			
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